Literature DB >> 17613014

Improvement of in vivo transfer of plasmid DNA in muscle: comparison of electroporation versus ultrasound.

Yoka H Kusumanto1, Nanno H Mulder, Wendy A Dam, Mario Losen, Mario H Losen, Marc H De Baets, Coby Meijer, Geke A P Hospers.   

Abstract

Plasmid-based gene delivery to muscle is a treatment strategy for many diseases with potential advantages above viral-based gene delivery methods, however, with a relative low transfection efficiency. We compared two physical methods - electroporation and ultrasound - that facilitate DNA uptake into cells. Mice (C57Bl/6) were injected intramuscular using plasmid DNA encoding an intracellular protein (p53) followed by electroporation or ultrasound. Then 48 hr after the injections the mice were sacrificed. The parameter for transfection efficiency was the area of muscle expressing the transgene. The p53 expression plasmid showed a 36-fold increase (p = 0.015) in transfection efficiency with electroporation compared to ultrasound. Compared with ultrasound, electroporation significantly improves transfection efficiency of naked plasmid DNA transfer into skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17613014     DOI: 10.1080/10717540601098807

Source DB:  PubMed          Journal:  Drug Deliv        ISSN: 1071-7544            Impact factor:   6.419


  8 in total

1.  New mechanisms for non-porative ultrasound stimulation of cargo delivery to cell cytosol with targeted perfluorocarbon nanoparticles.

Authors:  Nr Soman; Jn Marsh; Gm Lanza; Sa Wickline
Journal:  Nanotechnology       Date:  2008-05-07       Impact factor: 3.874

Review 2.  Electroporation for the delivery of DNA-based vaccines and immunotherapeutics: current clinical developments.

Authors:  Angela M Bodles-Brakhop; Richard Heller; Ruxandra Draghia-Akli
Journal:  Mol Ther       Date:  2009-02-17       Impact factor: 11.454

Review 3.  Gene electrotransfer: from biophysical mechanisms to in vivo applications : Part 2 - In vivo developments and present clinical applications.

Authors:  Jean-Michel Escoffre; Chloé Mauroy; Thomas Portet; Luc Wasungu; Aurelie Paganin-Gioanni; Muriel Golzio; Justin Teissié; Marie-Pierre Rols
Journal:  Biophys Rev       Date:  2009-11-10

4.  The expression patterns of beta1,4 galactosyltransferase I and V mRNAs, and Galbeta1-4GlcNAc group in rat gastrocnemius muscles post sciatic nerve injury.

Authors:  Meijuan Yan; Chun Cheng; Fei Ding; Jing Jiang; Lingling Gao; Chunlin Xia; Aiguo Shen
Journal:  Glycoconj J       Date:  2008-05-30       Impact factor: 2.916

5.  Prostate stem cell antigen DNA vaccination breaks tolerance to self-antigen and inhibits prostate cancer growth.

Authors:  Sarfraz Ahmad; Garrett Casey; Paul Sweeney; Mark Tangney; Gerald C O'Sullivan
Journal:  Mol Ther       Date:  2009-03-31       Impact factor: 11.454

6.  Improving the efficacy of therapeutic angiogenesis by UTMD-mediated Ang-1 gene delivery to the infarcted myocardium.

Authors:  Qing Deng; Bo Hu; Sheng Cao; Hong-Ning Song; Jin-Ling Chen; Qing Zhou
Journal:  Int J Mol Med       Date:  2015-05-28       Impact factor: 4.101

7.  Codon-Optimized P1A-Encoding DNA Vaccine: Toward a Therapeutic Vaccination against P815 Mastocytoma.

Authors:  Alessandra Lopes; Kevin Vanvarenberg; Véronique Préat; Gaëlle Vandermeulen
Journal:  Mol Ther Nucleic Acids       Date:  2017-07-13       Impact factor: 8.886

8.  DNA vaccination for prostate cancer, from preclinical to clinical trials - where we stand?

Authors:  Sarfraz Ahmad; Paul Sweeney; Gerald C Sullivan; Mark Tangney
Journal:  Genet Vaccines Ther       Date:  2012-10-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.